AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 16th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Pennsylvania
This Amended and Restated License Agreement (the “Agreement”), dated December 10, 2010 (the “Amendment Effective Date”) is made by and between GlaxoSmithKline LLC, formerly known as SmithKline Beecham Corporation (“GSK”), a Delaware limited liability company, and Unigene Laboratories, Inc. (“Unigene”), a Delaware corporation (each a “Party” and collectively, the “Parties”).
FORBEARANCE AGREEMENTForbearance Agreement • March 16th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
THIS FORBEARANCE AGREEMENT (this “Agreement”) is made as of December 8, 2010, by and among UNIGENE LABORATORIES, INC., a Delaware corporation (“Borrower”), VICTORY PARK MANAGEMENT, LLC, a Delaware limited liability company, as collateral agent and administrative agent (“Agent”) for the benefit of all Secured Parties (as defined in the Security Agreement), and the Secured Parties. Unless otherwise defined herein, capitalized terms used herein shall have the meanings ascribed to them in the Financing Agreement (as defined below).
Victory Park Management, LLCUnigene Laboratories Inc • March 16th, 2011 • Medicinal chemicals & botanical products • Illinois
We refer to (i) that certain Amended and Restated Financing Agreement, dated as of March 16, 2010, by and among Unigene Laboratories, Inc. (the “Borrower”), the Lenders identified therein and Victory Park Management, LLC, as administrative and collateral agent (the “Agent”) for the Lenders (as amended, modified or supplemented from time to time, the “Financing Agreement”) and the other Transaction Documents and (ii) that certain Forbearance Agreement of even date herewith by and among Borrower, Agent and the Secured Parties (as defined in the Security Agreement). Capitalized terms used but not defined herein have the meanings given to such terms in the Financing Agreement.
